A big surprise in the molecular cell biology of eukaryotes has been the discovery of pathways of protein secretion that are not linked to the endoplasmic reticulum (ER) and the Golgi apparatus. Various kinds of unconventional secretory processes have been described, including two major pathways for two distinct sets of cargoes that are initially synthesized as soluble proteins in the cytoplasm. These two pathways are mechanistically distinct from one another. One is based upon direct protein translocation across lipidic pores in the plasma membrane (type I unconventional secretion). The second pathway involves the recruitment of cytoplasmic proteins into vesicular compartments of the endocytic membrane system that fuse with the plasma membrane to release proteins into the extracellular space (type III unconventional secretion). This primer highlights the mechanisms and molecular machineries of these pathways that were discovered with fi broblast growth factor 2 (FGF2; type I) and acyl-CoA binding protein (Acb1; type III) as the most prominent cargo proteins. Furthermore, the physiological signifi cance of these secretory routes in both health and disease is discussed for a broader range of cargo proteins.
Diversity of secretory mechanisms in eukaryotic cells
For decades following the discovery of the ER-Golgi-dependent secretory pathway in eukaryotic cells ( Figure 1A ), it has been believed that all proteins destined for the extracellular space travel along this route. However, in the late 1980s, the fi rst reports appeared proposing alternative mechanisms of eukaryotic protein secretion to exist along with a number of possible secretory cargo proteins. reconstitution systems allowed for a breakthrough. An important fi nding was the discovery that FGF2 contains a highly specifi c binding pocket for the head group of phosphatidylinositol (4,5) bisphosphate (PI(4,5)P 2 ), a membrane lipid enriched at the inner leafl et of the plasma membrane. Studies from our lab in 2012 showed that this interaction triggered oligomerization of FGF2 followed by membrane insertion and the formation of a lipidic membrane pore with a toroidal architecture. Another key result was the discovery that membraneproximal heparan sulfates at the outer leafl et are not only required for FGF2 signaling but also essential for FGF2 secretion into the extracellular space. These fi ndings were corroborated by experiments demonstrating that FGF2 variant forms that are defective in binding to either PI(4,5)P 2 or heparan sulfates fail to get secreted from tumor cells. Biochemical and structural analyses revealed overlapping binding sites for PI(4,5)P 2 and heparan sulfates on the molecular surface of FGF2, resulting in mutually exclusive interactions of FGF2 with these two binding partners.
These studies triggered the assembly/disassembly hypothesis of FGF2 membrane translocation, which proposed that membraneinserted FGF2 oligomers act as dynamic translocation intermediates that are assembled at the inner leafl et in a PI(4,5)P 2 -dependent manner ( Figure 1B ). Based upon high-affi nity interactions of membrane-proximal heparan sulfates (K D 10 nM) that outcompete interactions of PI(4,5)P 2 with FGF2 (K D 1 µM) at the outer leafl et, membrane-inserted oligomers become disassembled, resulting in translocation of FGF2 to the cell surface. This model provides a mechanism that explains the directional transport of FGF2 from the cytoplasm into the extracellular space and is consistent with the observation that membrane translocation requires FGF2 to be properly folded during all stages of this process.
Recent work from our lab provided support for this hypothesis through a full reconstitution of the core mechanism of FGF2 membrane translocation using purifi ed components (Steringer et al. (2017) ). Using an inside-out membrane model
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The underlying molecular mechanisms only slowly emerged, resulting in the identifi cation of four distinct classes of unconventional secretory mechanism in eukaryotic cells (Figure 1) . Three of these concern soluble proteins in the cytoplasm that are either secreted through direct protein translocation across lipidic pores in the plasma membrane (type I; Figure 1B ), plasmamembrane-resident ABC transporters with the cargo proteins being modifi ed by acylation (type II; Figure 1C ), or uptake into endocytic compartments that mature and subsequently fuse with the plasma membrane (type III; Figure  1D ). A fourth variant of unconventional secretion refers to plasma-membraneresident integral membrane proteins that are inserted into the ER, but bypass the Golgi while traveling to the cell surface (type IV; Figure 1E ). In this primer, we focus on the type I and type III pathways of unconventional secretion where recent studies have elucidated the molecular mechanisms involved in the greatest detail.
Type I unconventional secretion of FGF2 from tumor cells FGF2 was among the earliest examples of unconventionally secreted proteins that were discovered in the late 1980s. This case was particularly compelling since the extracellular localization of this signal-peptidelacking protein was linked to a wellestablished function -the formation of a ternary signaling complex of FGF2 with heparan sulfates and FGF highaffi nity receptors on the cell surface of target cells. In this way, extracellular FGF2 transmits signals into cells that regulate a wide range of physiological responses, such as cell proliferation and differentiation. Furthermore, FGF2 signaling is not only critical during development but also plays prominent roles under pathophysiological conditions, promoting survival through an autocrine secretion/signaling pathway that protects tumor cells from programmed cell death.
Following a long period of very limited insight into the molecular mechanism by which tumor cells secrete FGF2, the emergence of advanced techniques, such as functional genomics based on RNAi screening, as well as the development of sophisticated membrane Current Biology 28, R367-R420, April 23, 2018 R407 system based upon giant unilamellar vesicles (GUVs), it was shown that PI(4,5)P 2 and heparan sulfates reconstituted on opposing sides of the membrane along with the ability of FGF2 to oligomerize and to form membrane pores in a PI(4,5)P 2 -dependent manner are together suffi cient as trans elements to drive FGF2 membrane translocation. This process depends on three critical cis elements in FGF2: the residues that form the binding pocket for PI(4,5)P 2 ; the residues forming the binding surface for heparan sulfates; and a cysteine residue in position 95 (Cys95) on the molecular surface of FGF2 that is critical for PI(4,5)P 2 -dependent oligomerization. Cys95 forms intermolecular disulfide bridges that are required for the biogenesis of membrane-inserted oligomers with 8 to 12 subunits being the threshold for the formation of membrane pores. All three of these cis elements have been confirmed to be required for FGF2 secretion from cells. In conclusion, as a result of the competing interactions of FGF2 with PI(4,5)P 2 versus heparan sulfates on opposing sides of the plasma membrane, the core process of unconventional secretion of FGF2 from cells is based upon an unusual mechanism of selfsustained membrane translocation with the cargo protein forming its own membrane translocation intermediates by reversible oligomerization, membrane insertion and disassembly in the extracellular space.
In a cellular context, beyond the core mechanism of FGF2 membrane translocation established through biochemical reconstitution experiments, additional auxiliary components have been identifi ed that support unconventional secretion of FGF2 from cells. Genome-wide RNAi screening identifi ed two additional trans-acting factors,Tec kinase and ATP1A1. Both factors are physically associated with the plasma membrane, Tec kinase through a pleckstrin homology (PH) domain that binds to PI(3,4,5)P 3 , and ATP1A1 as the -subunit of the Na + /K + ATPase. Direct interactions of FGF2 with both Tec kinase and the cytoplasmic domain of ATP1A1 have been demonstrated with sub-micromolar affi nities. While FGF2 Beyond the classical, ER-Golgi-dependent secretory pathway (A), four types of unconventional protein secretion (UPS) have been described. Those include direct protein translocation across lipidic pores in the plasma membrane (B; UPS type I), secretion through plasma-membrane-resident ABC transporters with the cargo proteins being modifi ed by acylation (C; UPS type II), secretion through uptake into endocytic compartments that mature and subsequently fuse with the plasma membrane (D; UPS type III) and transport of integral membrane proteins towards the plasma membrane bypassing the Golgi (E; UPS type IV). For details, see text. were incubated with recombinant AcbA, sporulation resumed because the protease that mobilizes SDF-2 from the AcbA precursor protein is a plasma-membrane-resident enzyme with its active center facing the extracellular space. Since AcbA must get transported into the extracellular space for cleavage to produce SDF-2 and lacks a signal peptide, it was proposed to follow an unconventional route of secretion. Intriguingly, Acb1, the yeast ortholog of AcbA, was also found to be secreted from yeast cells upon starvation, making the analysis of unconventional secretion of AcbA/ Acb1 amenable to genetic screening procedures to identify factors involved in this pathway. It was found that Acb1 secretion in yeast cells also depends on the yeast GRASP ortholog Grh1 and led to the discovery of Acb1 secretion being dependent on a set of gene products required for autophagy as well as on the plasma membrane SNARE protein Sso1. At the same time, Subramani and colleagues published similar results from a different organism, Pichia pastoris. These fi ndings were initially interpreted in terms of a direct role for autophagosomes in capturing Acb1 in the cytoplasm to follow a pathway of autophagy that does not end up with degradation of cargo proteins in lysosomes. Instead, it was proposed that this population of autophagosomes fuses with recycling compartments of the endocytic system. Upon fusion of such vesicular intermediates with the plasma membrane in an Sso1-dependent manner, Acb1 would be released into the extracellular space.
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In follow-up studies using starvation as a trigger, it was shown that an early event in the Acb1 secretion pathway is the formation of a cup-shaped compartment whose biogenesis depends on Grh1. It was termed CUPS for Compartment of Unconventional Protein Secretion for the type III pathway and proposed to mediate the initial sorting of Acb1 into its unconventional secretory pathway. This compartment is located in the vicinity of ER exit sites, contains Grh1 and the ESCRT component Vps23 but lacks factors derived from the Golgi and endosomes. As discussed above, initial results suggested that the CUPS structure represents a subpopulation of autophagosomes since colocalization with autophagy-related proteins was observed. However, later studies challenged these fi ndings, suggesting that CUPS is not directly related to autophagosomes. Recent work showed that starvation causes maturation of CUPS from immature forms into a stable structure that contains Acb1 and is characterized by a membrane-bound saccule with a heterogeneous population of vesicles and tubules sequestered inside ( Figure  1D ). The formation of this structure depends on the ESCRT complexes I, II and III, but is independent of Vps4, an AAA-ATPase that cooperates with ESCRT complexes in the formation of multivesicular bodies. Instead, another factor, Snf7, is recruited to the maturing CUPS compartment and is important for the biogenesis and the structural integrity of the saccule (Curwin et al. (2016) ). Subsequent processes involve Sso1-dependent fusion of CUPS with the plasma membrane, resulting in Acb1 secretion into the extracellular space. While the details of the maturation of the CUPS structure and late steps in CUPSmediated secretion of Acb1 remain to be resolved, these studies provide a fundamental explanation of how autophagosomes and MVBs differ both structurally and functionally from the CUPS compartment that is the central mediator of unconventional secretion of Acb1 as part of the type III pathway ( Figure 1D ).
Range of cargo proteins secreted by type I and type III pathways
The broad signifi cance of type I and type III pathways for other secretory proteins that bypass the ER-Golgi system is only beginning to emerge. A comprehensive review of our current knowledge about the range of cargo proteins for all four types of unconventional secretion has been published recently (Rabouille (2017) ). Here, we highlight selected examples for type I and type III secretion (Table  1) . Beyond FGF2, the most compelling example described so far for another cargo protein secreted through a type I mechanism is HIV-Tat, which is secreted from HIV-infected T cells through an unconventional pathway Current Biology 28, R367-R420, April 23, 2018 R409 that depends on PI(4,5)P 2 . Later, it was demonstrated that HIV-Tat shares many features of FGF2, including the ability to form oligomers and membrane pores in a PI(4,5)P 2 -dependent manner. Recently, a direct role for ATP1A1 in the unconventional secretion of HIV-Tat has been reported, another striking similarity with FGF2. Interestingly, under experimental conditions that trigger an infl ammatory response from macrophages, interleukin-1 (IL-1) secretion also appears to follow a type I pathway that is linked to a process called pyroptosis. While IL-1 itself does not have the ability to directly bind to PI(4,5)P 2 to form membrane pores, it has been suggested that, in this case, the observed pores might be formed by another factor, through which IL-1 may reach the extracellular space. Indeed, a protein termed Gasdermin is activated by proteolytic cleavage upon infl ammasome activation, with its active amino-terminal fragment driving membrane pore formation in a PI(4,5)P 2 -dependent manner. Additional candidates that follow a type I mechanism of unconventional secretion are annexin A2 and members of the galectin family of proteins (Table 1) .
Intriguingly, IL-1 is also capable of entering the type III pathway in macrophages, depending on a combination of stimuli that trigger autophagy and infl ammasome activation ( Figure 1D ). This process has also been studied by Schekman and colleagues in non-macrophage cell lines, defi ning specifi c conditions that lead to the capture and unconventional secretion of mature IL-1 by the type III pathway. It is, however, unclear whether the vesicular intermediates involved in this process are directly related to the CUPS compartment described for Acb1 secretion from yeast cells (as discussed in the previous section). Instead, both the Deretic and the Schekman laboratories related these vesicular carriers to autophagosomes and termed the overall process 'secretory autophagy' in mammalian cells. It therefore remains to be established whether Acb1 secretion from yeast cells and IL-1 secretion triggered by starvation of mammalian cells are directly related in terms of molecular machinery and mechanism. In any case, biochemical reconstitution experiments provided direct evidence that IL-1 does not reach the most inner lumen of autophagosomal membranes (corresponding topologically to the cytoplasm) but rather translocates into the intermembrane space of these membrane-bound compartments (topologically equivalent to the extracellular space). Upon fusion of these vesicular intermediates with the plasma membrane, this localization would allow for the direct release of IL-1 into the extracellular space ( Figure 1D ). The processes described for IL-1 all depend on GRASP directly linking these pathways to what has been originally found for AcbA/Acb1 in Dictyostelium and yeast cells (see above). In addition, all of these processes depend on several gene products required for the induction of autophagy, factors involved in the biogenesis of MVBs, and dedicated SNARE proteins that mediate fusion events at the plasma membrane, separating this process from membrane traffi cking pathways delivering proteins to lysosomes for degradation. The latter is strongly supported by experiments demonstrating that secretory autophagy is unaffected or, in fact, even enhanced when membrane fusion of autophagosomes with lysosomes is blocked. Thus, under conditions that trigger autophagy, such as starvation, AcbA/Acb1 and IL-1 are cargo proteins that defi ne the type III pathway of unconventional secretion in various organisms (Table 1) . Recent studies have shown that superoxide dismutase 1 (SOD1), which is linked to amyotrophic lateral sclerosis (ALS), is secreted by the type III pathway. Intriguingly, sorting of SOD1 into the Figure 1E) , are rare and unusual cases of protein transport along the ER-Golgi route or whether a given physiological context such as cellular stress might have a broad impact on the classical secretory pathway, rerouting many proteins to ensure proper protein targeting under these conditions. In any case, it is fascinating to observe that eukaryotic cells evolved a broad variety of secretory mechanisms that are much more complex than previously assumed. It will be a challenge to reveal both the molecular mechanisms and the physiological signifi cance of these pathways for a larger set of cargo proteins as well as to make use of this knowledge to develop highly specifi c drugs that prevent the secretion of individual proteins under pathophysiological conditions.
